Empirical evidence of risk penalties for NTI Drugs
Crossref DOI link: https://doi.org/10.1007/s11166-019-09304-6
Published Online: 2019-06-13
Published Print: 2019-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gentry, Elissa Philip
Text and Data Mining valid from 2019-06-01
Version of Record valid from 2019-06-01
Article History
First Online: 13 June 2019